Risultati della ricerca - Anne‐Marie C. Dingemans

Raffina i risultati
  1. 1
    Heat shock protein antagonists in early stage clinical trials for NSCLC

    Heat shock protein antagonists in early stage clinical trials for NSCLC di Lizza Hendriks, Anne‐Marie C. Dingemans

    Pubblicazione 2017
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  2. 2
    Immunotherapy for nonsmall cell lung cancer: a new therapeutic algorithm

    Immunotherapy for nonsmall cell lung cancer: a new therapeutic algorithm di Thierry Berghmans, Anne‐Marie C. Dingemans, Lizza Hendriks, J. Cadranel

    Pubblicazione 2020
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  3. 3
    Immunotherapy: From Advanced NSCLC to Early Stages, an Evolving Concept

    Immunotherapy: From Advanced NSCLC to Early Stages, an Evolving Concept di Thierry Berghmans, Valérie Durieux, Lizza Hendriks, Anne‐Marie C. Dingemans

    Pubblicazione 2020
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  4. 4
    Response Assessment Using <sup>18</sup>F-FDG PET Early in the Course of Radiotherapy Correlates with Survival in Advanced-Stage Non–Small Cell Lung Cancer

    Response Assessment Using <sup>18</sup>F-FDG PET Early in the Course of Radiotherapy Correlates with Survival in Advanced-Stage Non–Small Cell Lung Cancer di Wouter van Elmpt, Michel Öllers, Anne‐Marie C. Dingemans, Philippe Lambin, Dirk De Ruysscher

    Pubblicazione 2012
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  5. 5
    MicroRNA Expression and Clinical Outcome of Small Cell Lung Cancer

    MicroRNA Expression and Clinical Outcome of Small Cell Lung Cancer di Jih‐Hsiang Lee, Johannes Voortman, Anne‐Marie C. Dingemans, Donna Voeller, Trung C. Pham, Yisong Wang, Giuseppe Giaccone

    Pubblicazione 2011
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  6. 6
    Management of stage I and II nonsmall cell lung cancer

    Management of stage I and II nonsmall cell lung cancer di Fiona McDonald, Michèle De Waele, Lizza Hendriks, Corinne Faivre‐Finn, Anne‐Marie C. Dingemans, Paul Van Schil

    Pubblicazione 2016
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  7. 7
    New Insights into the Molecular Characteristics of Pulmonary Carcinoids and Large Cell Neuroendocrine Carcinomas, and the Impact on Their Clinical Management

    New Insights into the Molecular Characteristics of Pulmonary Carcinoids and Large Cell Neuroendocrine Carcinomas, and the Impact on Their Clinical Management di Jules L. Derks, Noémie Leblay, Sylvie Lantuéjoul, Anne‐Marie C. Dingemans, Ernst‐Jan M. Speel, Lynnette Fernández-Cuesta

    Pubblicazione 2018
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  8. 8
    Effect of Bisphosphonates, Denosumab, and Radioisotopes on Bone Pain and Quality of Life in Patients with Non–Small Cell Lung Cancer and Bone Metastases: A Systematic Review

    Effect of Bisphosphonates, Denosumab, and Radioisotopes on Bone Pain and Quality of Life in Patients with Non–Small Cell Lung Cancer and Bone Metastases: A Systematic Review di Lizza Hendriks, B.C.M. Hermans, M.H.J. van den Beuken-van Everdingen, Monique Hochstenbag, Anne‐Marie C. Dingemans

    Pubblicazione 2015
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  9. 9
    [18F]fluorodeoxyglucose Uptake Patterns in Lung Before Radiotherapy Identify Areas More Susceptible to Radiation-Induced Lung Toxicity in Non-Small-Cell Lung Cancer Patients

    [18F]fluorodeoxyglucose Uptake Patterns in Lung Before Radiotherapy Identify Areas More Susceptible to Radiation-Induced Lung Toxicity in Non-Small-Cell Lung Cancer Patients di Steven Petit, Wouter J. C. van Elmpt, Cary Oberije, Erik Vegt, Anne‐Marie C. Dingemans, Philippe Lambin, André Dekker, Dirk De Ruysscher

    Pubblicazione 2010
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  10. 10
    Integrin expression profiling identifies integrin alpha5 and beta1 as prognostic factors in early stage non-small cell lung cancer

    Integrin expression profiling identifies integrin alpha5 and beta1 as prognostic factors in early stage non-small cell lung cancer di Anne‐Marie C. Dingemans, Vivian van den Boogaart, Bettine A.H. Vosse, Robert‐Jan van Suylen, Arjan W. Griffioen, Victor L. Thijssen

    Pubblicazione 2010
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  11. 11
    Early Weight Loss during Chemoradiotherapy Has a Detrimental Impact on Outcome in NSCLC

    Early Weight Loss during Chemoradiotherapy Has a Detrimental Impact on Outcome in NSCLC di Karin J.C. Sanders, Lizza Hendriks, Esther G.C. Troost, Gerben Bootsma, Ruud Houben, Annemie M.W.J. Schols, Anne‐Marie C. Dingemans

    Pubblicazione 2016
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  12. 12
    Defining Synchronous Oligometastatic Non–Small Cell Lung Cancer: A Systematic Review

    Defining Synchronous Oligometastatic Non–Small Cell Lung Cancer: A Systematic Review di Niccolò Giaj-Levra, Matteo Giaj Levra, Valérie Durieux, Silvia Novello, Benjamin Besse, Baktiar Hasan, Lizza Hendriks, Antonin Lévy, Anne‐Marie C. Dingemans, Thierry Berghmans

    Pubblicazione 2019
    Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  13. 13
    Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: Results from a population-based study

    Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: Results from a population-based study di Lizza Hendriks, Jules L. Derks, Pieter E. Postmus, Ronald Damhuis, Ruud Houben, Esther G.C. Troost, M. Hochstenbag, Egbert F. Smit, Anne‐Marie C. Dingemans

    Pubblicazione 2015
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  14. 14
    Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment?

    Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment? di Joline S.W. Lind, Martijn R. Meijerink, Anne‐Marie C. Dingemans, Cornelis van Kuijk, Michel Öllers, Dirk De Ruysscher, Pieter E. Postmus, Egbert F. Smit

    Pubblicazione 2010
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  15. 15
    Progression-Free Survival and Overall Survival Beyond 5 Years of NSCLC Patients With Synchronous Oligometastases Treated in a Prospective Phase II Trial (NCT 01282450)

    Progression-Free Survival and Overall Survival Beyond 5 Years of NSCLC Patients With Synchronous Oligometastases Treated in a Prospective Phase II Trial (NCT 01282450) di Dirk De Ruysscher, Rinus Wanders, Lizza Hendriks, Angela van Baardwijk, Bart Reymen, Ruud Houben, Gerben Bootsma, Cordula Pitz, Linda van Eijsden, Anne‐Marie C. Dingemans

    Pubblicazione 2018
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  16. 16
    Nuclear transcription factor κ B activation and protein turnover adaptations in skeletal muscle of patients with progressive stages of lung cancer cachexia

    Nuclear transcription factor κ B activation and protein turnover adaptations in skeletal muscle of patients with progressive stages of lung cancer cachexia di Celine M. Op den Kamp, Ramon Langen, Frank J. M. Snepvangers, Chiel C. de Theije, Johanna M Schellekens, Fabian Laugs, Anne‐Marie C. Dingemans, Annemie Schols

    Pubblicazione 2013
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  17. 17
    Mature Results of an Individualized Radiation Dose Prescription Study Based on Normal Tissue Constraints in Stages I to III Non–Small-Cell Lung Cancer

    Mature Results of an Individualized Radiation Dose Prescription Study Based on Normal Tissue Constraints in Stages I to III Non–Small-Cell Lung Cancer di Angela van Baardwijk, S. Wanders, Liesbeth Boersma, Jacques Borger, Michel Öllers, Anne‐Marie C. Dingemans, Gerben Bootsma, Wiel Geraedts, Cordula Pitz, Ragnar Lunde, Philippe Lambin, Dirk De Ruysscher

    Pubblicazione 2010
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  18. 18
    Is the sum of positive neuroendocrine immunohistochemical stains useful for diagnosis of large cell neuroendocrine carcinoma (LCNEC) on biopsy specimens?

    Is the sum of positive neuroendocrine immunohistochemical stains useful for diagnosis of large cell neuroendocrine carcinoma (LCNEC) on biopsy specimens? di Jules L. Derks, Anne‐Marie C. Dingemans, Robert‐Jan van Suylen, Michael A. den Bakker, Ronald Damhuis, Esther C. van den Broek, Ernst‐Jan Speel, Erik Thunnissen

    Pubblicazione 2018
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  19. 19
    Handgrip weakness, low fat‐free mass, and overall survival in non‐small cell lung cancer treated with curative‐intent radiotherapy

    Handgrip weakness, low fat‐free mass, and overall survival in non‐small cell lung cancer treated with curative‐intent radiotherapy di Chris Burtin, Jacques Bezuidenhout, Karin J.C. Sanders, Anne‐Marie C. Dingemans, Annemie M.W.J. Schols, Stéphanie Peeters, Martijn A. Spruit, Dirk K.M. De Ruysscher

    Pubblicazione 2020
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  20. 20
    Pre-cachexia in patients with stages I–III non-small cell lung cancer: Systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome system

    Pre-cachexia in patients with stages I–III non-small cell lung cancer: Systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome sy... di Celine M. Op den Kamp, Ramon Langen, Ronnie Minnaard, Marco Kelders, Frank J. M. Snepvangers, M. K.C. Hesselink, Anne‐Marie C. Dingemans, Annemie M.W.J. Schols

    Pubblicazione 2011
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:

Strumenti per la ricerca: